Domestic Animal Endocrinology
Volume 39, Issue 4 , Pages 222-230 , November 2010

Effect of hyperlipidemia on 11β-hydroxysteroid-dehydrogenase, glucocorticoid receptor, and leptin expression in insulin-sensitive tissues of cats

Part of the present study was presented as an abstract at the 26th ACVIM Congress, San Antonio, TX, USA, June 4–7, 2008.

  • Nadja S. Sieber-Ruckstuhl

      Affiliations

    • Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: + 41 44 635 83 01; fax: + 41 44 635 89 30
    • ,
  • Eric Zini

      Affiliations

    • Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
    • ,
  • Melanie Osto

      Affiliations

    • Institute of Veterinary Physiology and Centre of Integrative Human Physiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
    • ,
  • Marco Franchini

      Affiliations

    • Institute of Virology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
    • ,
  • Felicitas S. Boretti

      Affiliations

    • Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
    • ,
  • Marina L. Meli

      Affiliations

    • Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Switzerland
    • ,
  • Brigitte Sigrist

      Affiliations

    • Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
    • ,
  • Thomas A. Lutz

      Affiliations

    • Institute of Veterinary Physiology and Centre of Integrative Human Physiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
    • ,
  • Claudia E. Reusch

      Affiliations

    • Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland

References 

  1. Andrew R, Phillips DIW, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab. 1998;83:1806–1809
  2. Stulnig TM, Waldhäusl W. 11β-hydroxysteroid dehydrogenase type 1 in obesity and type 2 diabetes. Diabetologia. 2004;47:1–11
  3. Perley M, Kipnis DM. Effect of glucocorticoids on plasma insulin. N Engl J Med. 1966;274:1237–1241
  4. Olefsky JM, Kimmerling G. Effects of glucocorticoids on carbohydrate metabolism. Am J Med Sci. 1976;271:202–210
  5. Nosadini R, Del Prato S, Tiengo A, Valerio A, Muggeo M, Opocher G, et al. Insulin resistance in Cushing's Syndrome. J Clin Endocrinol Metab. 1983;57:529–536
  6. Agarwal AK, Monder C, Eckstein B, White PC. Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J Biol Chem. 1989;264:18939–18943
  7. Ricketts ML, Verhaeg JM, Bujalska I, Howie AJ, Rainey WE, Stewart PM. Immunohistochemical localization of type 1 11β-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab. 1998;83:1325–1335
  8. Edwards CRW, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WE, et al. Localisation of 11β-hydroxysteroid dehydrogenase – tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2:986–989
  9. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol. 1994;105:R11–R17
  10. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mulling JJ, Seckl JR, et al. A transgenic model of visceral obesity and metabolic syndrome. Science. 2001;294:2166–2170
  11. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, et al. 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A. 1997;94:14924–14929
  12. Morton NM, Holmes MC, Fiévet C, Staels B, Tailleux A, Mullins JJ, et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J Biol Biochem. 2001;276:41293–41300
  13. Alberts P, Engblom L, Edling N, Forsgren M, Klingström G, Larsson C, et al. Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia. 2002;45:1528–1532
  14. Hermanowski-Vosatka A, Balkovec M, Cheng K, Chen HY, Hernandez M, Koo GC, et al. 11β-hydroxysteroid dehydrogenase type 1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med. 2005;202:517–527
  15. McGarry JD. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51:7–18
  16. Greenfield JR, Campbell LV. Relationship between inflammation, insulin resistance and type 2 diabetes: cause or effect?. Curr Diabetes Rev. 2006;2:195–211
  17. Boden G. Free fatty acids (FFA), a link between obesity and insulin resistance. Front Biosci. 1998;3:D169–D175
  18. Lam TK, Van De Werve G, Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab. 2003;284:E281–E290
  19. Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, et al. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance. Clin Endocrinol. 2005;63:442–449
  20. Wake DJ, Homer NZM, Andrew R, Walker BR. Acute in vivo regulation of 11β-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans. J Clin Endocrinol Metab. 2006;91:4682–4688
  21. Lutz TA, Rand JS. Pathogenesis of feline diabetes mellitus. Vet Clin North Am Small Anim Pract. 1995;25:527–552
  22. Cefalu WT. Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. ILAR J. 2006;47:186–198
  23. Henson MS, O'Brien TD. Feline models of type 2 diabetes mellitus. ILAR J. 2006;47:234–242
  24. Ettinger SJ, Feldman EC. Textbook of Veterinary Internal Medicine. 7th ed.. St. Louis, Missouri: Saunders Elsevier; 2010;
  25. Zini E, Osto M, Franchini M, Guscetti F, Donath MY, Perren A, et al. Hyperglycemia but not hyperlipidemia causes beta cell dysfunction and beta cell loss in the domestic cat. Diabetologia. 2009;52:336–346
  26. Thiess S, Becskei C, Tomsa K, Lutz TA, Wanner M. Effect of high carbohydrate and high fat diet on plasma metabolite levels and iv glucose tolerance test in intact and neutered male cats. J Fel Med Surg. 2004;6:207–218
  27. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–1470
  28. Leutenegger CM, Mislin CN, Sigrist B, Ehrengruber MU, Hofmann-Lehmann R, Lutz H. Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet Immunol Immunopathol. 1999;71:291–305
  29. Sieber-Ruckstuhl NS, Meli ML, Boretti FS, Gönczi E, Lutz H, Reusch CE. Quantitative real-time PCR for the measurement of 11β-HSD1 and 11β-HSD2 mRNA levels in tissues of healthy dogs. Horm Metab Res. 2007;39:548–554
  30. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996;97:2859–2865
  31. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Fürnsinn C, et al. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes. 1999;48:358–364
  32. Storgaard H, Jensen CB, Björnholm M, Song XM, Madsbad S, Zierath JR, et al. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. J Clin Endocrinol Metab. 2004;89:1301–1311
  33. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes. 2005;54:1640–1648
  34. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116:3015–3025
  35. Xiao C, Giacca A, Lewis GF. Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men. Diabetologia. 2008;51:139–146
  36. Wake DJ, Rask E, Livingstone DE, Söderberg S, Olsson T, Walker BR. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab. 2003;88:3983–3988
  37. Okada S, York DA, Bray GA. Mifepristone (RU486), a blocker of type II glucocorticoid and progestin receptors, reverses a dietary form of obesity. Am J Physiol. 1992;262:R1106–R1110
  38. Jenson M, Kilroy G, York DA, Braymer D. Abnormal regulation of hepatic glucocorticoid receptor mRNA and receptor protein distribution in the obese Zucker rat. Obes Res. 1996;4:133–143
  39. Liu Y, Nakagawa Y, Wang Y, Sakurai R, Tripathi PV, Lutfy K, et al. Increased glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes. 2005;54:32–40
  40. Watts LM, Manchem VP, Leedom TA, Rivard AL, McKay RA, Bao D, et al. Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism. Diabetes. 2005;54:1846–1853
  41. Rebuffé-Scrive M, Brönnegard M, Nilsson A, Eldh J, Gustafsson J, Björntorp P. Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab. 1990;71:1215–1219
  42. Hoenig M, Thomaseth K, Waldron M, Ferguson DC. Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. Am J Physiol Regul Integr Comp Physiol. 2007;292:R227–R234
  43. Seidell JC, Björntorp P, Sjöström L, Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose and C-peptide levels, but negatively with testosterone levels. Metabolism. 1990;39:897–901
  44. Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes. 2006;55:978–987
  45. Handjieva-Darlenska T, Boyadjieva N. The effect of high-fat diet on plasma ghrelin and leptin levels in rats. J Physiol Biochem. 2009;65:157–164
  46. Belsito KR, Vester BM, Keel T, Graves TK, Swanson KS. Impact of ovariohysterectomy and food intake on body composition, physical activity, and adipose gene expression in cats. J Anim Sci. 2009;87:594–602
  47. Paulmyer-Lacroix O, Boullu S, Oliver Ch, Alessi M, Grino M. Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: An in situ hybridization study. J Clin Endocrinol Metab. 2002;87:2701–2705
  48. Rask E, Walker BR, Söderberg S, Livingstone DEW, Eliasson M, Johnson O, et al. Tissue-specific changes in pheripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab. 2002;87:3330–3336

PII: S0739-7240(10)00072-X

doi: 10.1016/j.domaniend.2010.06.003

Domestic Animal Endocrinology
Volume 39, Issue 4 , Pages 222-230 , November 2010

Article Tools

* Image Usage & Resolution